ArticleSmall methods2025
Modular Droplet-Based Microfluidic Platform for Functional Phenotypic Screening of Natural Killer Cells.
Article in Small methods, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Machine vision-enabled ODThe Analyst · 2026Article
- From single cell analysis to 3D micro physiological systems: microfluidic tools integrating cancer cell targets for delineating natural killer cell biology.Microsystems & nanoengineering · 2026Review
- Applying microfluidic technology to interpret the tumor immune microenvironment and cancer immunotherapy.Cancer biology & medicine · 2026Review
- Modular Droplet-Based Microfluidic Platform for Functional Phenotypic Screening of Natural Killer Cells.Small methods · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Natural Killer (NK) cells, as key effector cells of the innate immune system, display high heterogeneity in their ability to kill target cells. The underlying mechanisms remain poorly understood. Here, a droplet-based microfluidic platform is presented to identify and select NK cells with serial killing ability. To this end, primary human NK cells are encapsulated with several target cells using an efficient negative pressure-based droplet generator. Capitalizing on the large number of possible killing events due to quantization into droplets, a convolutional neural network analysis pipeline is developed to quantify the cytotoxicity and abundance of serial killing events with high accuracy. To physically select NK cells based on their serial killing ability, MultiCell-Sort - an advanced real-time image-based droplet sorting module - is presented. While conventional single-cell sorters mostly evaluate intrinsically-encoded properties, such as protein expression levels, MultiCell-Sort can select living NK cells based on complex functional phenotypes emerging from multiple cell-cell interactions within the droplet. This novel microfluidic phenotyping platform hereby allows the potential integration of complementary techniques to provide an understanding of regulators and markers underlying the heterogeneous nature of NK cell functional phenotypes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.